Oberheiden, P.C. Blog

100 FAQs: DEA Opioid Investigations

Categories: Health Care Law

DEA Defense Attorney Dr. Nick Oberheiden The practice of authorizing and dispensing controlled substances has dramatically changed since the Justice Department announced to fight the national opioid crisis by vigorously prosecuting prescribers and corroborating pharmacies across the country. The essence of the government’s claim is that many of the close to 50 billion annual dosages…

Read More

The Opioid Crisis and the Risks Facing Health Care Providers

Categories: Health Care Law

opioid prescription bottle

Leading Federal Lawyers for Fraud Defense of Opioid Providers Opioid abuse is a major issue in the United States, and federal authorities are using a variety of different mechanisms to combat misuse of both prescription opioid medications and illegal drugs such as heroin, fentanyl, and carfentanil. Along with outreach and education, authorities such as the…

Read More

Justice Department Likely to Target Pain Management “Pill Mills” in 2018

Categories: Health Care Law

opioids pain management

Effective Federal “Pill Mill” Defense Lawyers With the nation’s opioid crisis continuing to garner headlines, federal prosecutors at the U.S. Department of Justice (DOJ) and other agencies are aggressively targeting those who supply drugs to opioid-dependent individuals. While this includes drug dealers who sell heroin and fentanyl, it also includes physicians and pharmacists who prescribe…

Read More

What Is Drug Diversion?

Categories: Criminal Law & Process

drug diversion

Drug diversion in the context of controlled substances occupies a major priority of current federal law enforcement. Almost no day goes by without new reports of arrest, DEA search warrants, and charges involving narcotics and other controlled prescription drugs. What does it mean when someone is accused of diverting drugs? And what should medical providers…

Read More